PP
ASMB icon

Paloma Partners’s Assembly Biosciences ASMB Stock Holding History

Paloma Partners’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4,717
Closed -$314K – 1824
2016
Q2 		$314K Buy
+4,717
New +$310K ﹤0.01% 1743
2013
Q3 		– Sell
-1,408
Closed -$203K – 914
2013
Q2 		$203K Buy
+1,408
New +$221K 0.01% 933

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Paloma Partners's ASMB Position: Q3 2016 in Review

Paloma Partners sold out of Assembly Biosciences (ASMB) in Q3 2016, closing a stake of 4,717 shares — an estimated $314K sold.

Paloma Partners first reported a position in ASMB in Q2 2013 and held it in 2 quarters. The position peaked at $314K in Q2 2016. 36 funds tracked by Wall St. Rank hold ASMB as of Q3 2016.

  • Paloma Partners reported no remaining Assembly Biosciences position as of Q3 2016 after selling out during the quarter.
  • Paloma Partners sold 4,717 Assembly Biosciences shares in Q3 2016, an estimated $314K.
  • Paloma Partners first reported a position in Assembly Biosciences in Q2 2013 and held it in 2 quarters.
  • Paloma Partners's Assembly Biosciences position peaked at $314K in Q2 2016.
  • 36 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2016.

Based on Paloma Partners's 13F filing for Q3 2016, filed 14 Nov 2016.